Position in HROW
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,394,075
+$565,175 QoQ
Shares Held
56,371
+8.7% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 223 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $549,104,897 across 28 Drug Manufacturers - Specialty & Generic names. HROW ranks #23 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,360 | $59,091,431 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
1,667,073 | $57,797,420 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
106,561 | $57,737,945 | |
| 4 | ALKS |
Alkermes plc.
|
983,822 | $51,552,272 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
239,193 | $40,313,587 | |
| 6 | ZTS |
Zoetis Inc.
|
527,859 | $37,931,946 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
772,174 | $31,682,298 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,133,913 | $27,905,598 |
All Filings in HROW
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,394,075 | 56,371 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,828,900 | 51,869 | Shares | Defined | 2026-05-04 | |
| 2025-03-31 | $201,468 | 7,574 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $256,287 | 7,639 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $329,106 | 7,320 | Shares | Defined | 2024-10-31 | |
| 2022-03-31 | $71,398 | 10,469 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $135,760 | 15,713 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||